Quantbot Technologies LP Bicycle Therapeutics PLC Put Options Transaction History
Quantbot Technologies LP
- $2.5 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCYC
# of Institutions
109Shares Held
41.7MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$117 Million2.28% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$43.1 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$32.6 Million0.17% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$28.1 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$24.4 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $371M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...